MedPharm Publications
  • Home
  • Journals
    • JEMDSA
    • JMLSTSA
    • PNT
    • SAJAA
    • SAJCN
    • SAJGO
    • SAJS
    • SAPA
    • SAGP
    • SAOJ
    • SAPJ
    • WHSA
  • News
  • Events
  • Advertise
  • CPD
  • Contact Us
Select Page

Uncontrolled diabetes makes the fight against COVID-19 harder

by Chandré Blignaut | Jul 27, 2020 | Featured, JEMDSA, News

Uncontrolled diabetes makes the fight against COVID-19 harder Since being declared a global pandemic by the World Health Organization (WHO)[1]  earlier this year, COVID-19 cases around the world have continued to increase at an alarming rate with over 11 million[2]...
dormakaba campaigns for robust hygiene and infection protection access control

dormakaba campaigns for robust hygiene and infection protection access control

by Chandré Blignaut | Jul 27, 2020 | Featured, News

dormakaba campaigns for robust hygiene and infection protection access control At this time of social distancing and hygiene control because of the advent of COVID-19, the ability to regulate access in high volume public areas and businesses is critical. Leading...
Dementia caregivers must take care of their own mental health during COVID-19, or risk burnout

Dementia caregivers must take care of their own mental health during COVID-19, or risk burnout

by Chandré Blignaut | Jul 27, 2020 | Featured

Dementia caregivers must take care of their own mental health during COVID-19, or risk burnout South Africans — and the world — are now months into “shelter at home” decrees, as the novel coronavirus (COVID-19) continues to make its devastating mark on the world. For...
New affordable broad-spectrum IV antibiotic launched to treat SA’s critically ill

New affordable broad-spectrum IV antibiotic launched to treat SA’s critically ill

by Chandré Blignaut | Jul 27, 2020 | Featured, News, SAGP, SAJS, SAPJ, WHSA

New affordable broad-spectrum IV antibiotic launched to treat SA’s critically ill South African hospitals will be given a wider choice of high-quality generic intravenous (IV) treatments at a much lower cost – the savings of which will benefit not only SA’s struggling...
Pharma Dynamics launches affordable antipsychotic ODT

Pharma Dynamics launches affordable antipsychotic ODT

by Chandré Blignaut | Jul 8, 2020 | Featured, News, SAGP

Pharma Dynamics launches affordable antipsychotic ODT Doctors can now prescribe an affordable orally dispersible tablet (ODT), called Zoxadon ODT to treat patients with schizophrenia, bipolar and other mood or disruptive disorders in children and adults. Abdurahmaan...
© 2020 Medpharm Publications